These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27330162)

  • 1. Are we too lenient with immunosuppression in severe cases of Systemic Sclerosis?
    Siegert E; Riemekasten G
    Rheumatology (Oxford); 2016 Oct; 55(10):1914-6. PubMed ID: 27330162
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a therapeutic role for immunosuppression for gastrointestinal involvement in patients with systemic sclerosis?
    McMahan ZH; Hughes M
    Rheumatology (Oxford); 2024 Jul; 63(7):1766-1768. PubMed ID: 38109678
    [No Abstract]   [Full Text] [Related]  

  • 3. Connective tissue diseases: Immunosuppressive therapy in SSc: what is the target?
    Boin F; Wigley F
    Nat Rev Rheumatol; 2009 Jul; 5(7):357-8. PubMed ID: 19568247
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic sclerosis].
    Peltomaa R; Pettersson T; Tuompo R; Luosujärvi R
    Duodecim; 2013; 129(19):1981-91. PubMed ID: 24218729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
    Sicińska J; Rudnicka L
    Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of severe systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis].
    Giebel S; Zoń-Giebel A; Błach A; Kucharz EJ; Hołowiecki J
    Pol Arch Med Wewn; 2003 Aug; 110(2):891-7. PubMed ID: 14682229
    [No Abstract]   [Full Text] [Related]  

  • 7. Early systemic sclerosis-opportunities for treatment.
    Sakkas LI; Simopoulou T; Katsiari C; Bogdanos D; Chikanza IC
    Clin Rheumatol; 2015 Aug; 34(8):1327-31. PubMed ID: 25711876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can we learn from negative clinical trials in systemic sclerosis?
    Veale DJ
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S1-4. PubMed ID: 20576207
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic sclerosis-clinical picture, diagnosis, and treatment].
    Becker MO; Distler O; Maurer B
    Z Rheumatol; 2019 Jun; 78(5):439-457. PubMed ID: 31089800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleroderma in children.
    Zulian F
    Pediatr Clin North Am; 2005 Apr; 52(2):521-45, vii. PubMed ID: 15820378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-synthetase syndrome positive for anti-isoleucyl-tRNA synthetase antibodies: an unusual case overlapping with systemic sclerosis and Sjogren's syndrome.
    Hervier B; Lambert M; Hachulla E; Musset L; Benveniste O; Piette JC; Amoura Z; Costedoat-Chalumeau N
    Rheumatology (Oxford); 2011 Jun; 50(6):1175-6. PubMed ID: 21454309
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic sclerosis].
    Villiger PM
    Ther Umsch; 2008 May; 65(5):283-7. PubMed ID: 18622933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis.
    Hughes M; Herrick A
    Br J Hosp Med (Lond); 2012 Sep; 73(9):509-10, 511-6. PubMed ID: 23124403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients.
    Hatta Y; Hasegawa M; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K
    Mod Rheumatol; 2014 Mar; 24(2):377-9. PubMed ID: 24593219
    [No Abstract]   [Full Text] [Related]  

  • 15. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JID VisualDx Quiz: August 2013.
    Styperek A; Kirsner RS
    J Invest Dermatol; 2013 Aug; 133(8):e7. PubMed ID: 23856936
    [No Abstract]   [Full Text] [Related]  

  • 17. New treatments in scleroderma: the rheumatologic perspective.
    Righi A; Cerinic MM
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):431-2. PubMed ID: 12428830
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic leg ulceration as the presenting feature of diffuse systemic sclerosis in childhood.
    Wahezi DM; Ilowite NT; Kenney-Riley KM; Belamarich PF
    J Pediatr; 2011 Oct; 159(4):698. PubMed ID: 21784448
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab: a potential therapeutic advance in scleroderma: what is the evidence?
    Simms RW; Lafyatis R
    Rheumatology (Oxford); 2010 Feb; 49(2):201-2. PubMed ID: 20032221
    [No Abstract]   [Full Text] [Related]  

  • 20. Corticosteroids in Myositis and Scleroderma.
    Postolova A; Chen JK; Chung L
    Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.